Rifadin and hepatocellular damage Patient Reports February 12, 2012

Rifadin Side Effects Report #4997891-2
Rifadin side effect was reported by a Consumer or non-health professional from on May 02, 2006. Male patient, 77 years of age, weighting 165.3 lb, was diagnosed with sepsis  and was treated with Rifadin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatitis fulminant, hepatocellular damage, prothrombin level decreased. Rifadin dosage: unknown. During the same period patient was treated with OFLOCET, LASILIX, PROZAC, SECTRAL, SPECIAFOLDINE, EUTHYRAL, MOPRAL, TIAPRIDAL. Patient died on 02/07/2006.

Rifadin Side Effects Report #5042902-1
Rifadin side effect was reported by a Consumer or non-health professional from on June 29, 2006. Male patient, 85 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifadin. After drug was administered, patient experienced the following side effects: anorexia, blood alkaline phosphatase increased, hepatitis , hepatocellular damage, jaundice , nausea . Rifadin dosage: unknown. During the same period patient was treated with PIRILENE, RIMIFON, MYAMBUTOL. Patient was hospitalized. Patient died on 04/16/2006.

Rifadin Side Effects Report #5573502-2
Rifadin side effect was reported by a Consumer or non-health professional from on Dec 18, 2007. Male patient, 46 years of age, was diagnosed with pulmonary tuberculosis and was treated with Rifadin. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, coagulation factor v level decreased, hepatitis fulminant, hepatocellular damage, jaundice , nausea , prothrombin level decreased. Rifadin dosage: unknown. During the same period patient was treated with PIRILENE, RIFATER. Patient recovered.

Rifadin Side Effects Report #5311481-3
Rifadin side effect was reported by a Consumer or non-health professional from on Apr 24, 2007. Female patient, 84 years of age, weighting 147.7 lb, was treated with Rifadin. After drug was administered, patient experienced the following side effects: hepatic failure, hepatocellular damage, hyperbilirubinaemia, prothrombin level decreased, renal failure acute. Rifadin dosage: unknown. During the same period patient was treated with RIFATER, PIRILENE, SOLUPRED, MYAMBUTOL, RIMIFON, METFORMIN, DIGOXIN. Patient was hospitalized. Patient died on 01/21/2007.


Rifadin Side Effects Report #4753538-1
Rifadin side effect was reported by a Consumer or non-health professional from on Nov 02, 2004. Male patient, 76 years of age, weighting 216.1 lb, was diagnosed with arthritis bacterial, staphylococcal infection  and was treated with Rifadin. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, cholestasis, cytolytic hepatitis, encephalopathy, hepatocellular damage, jaundice , oesophageal candidiasis, portal hypertension, vomiting. Rifadin dosage: unknown. During the same period patient was treated with TAVANIC, LASILIX, ORBENINE, ALDACTONE, THIAMINE. Patient was hospitalized. Patient died on 01/19/2005.

Rifadin Side Effects Report #5283082-7
Rifadin side effect was reported by a Consumer or non-health professional from on Mar 22, 2007. Female patient, 74 years of age, was treated with Rifadin. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, hepatic steatosis, hepatocellular damage, transaminases increased. Rifadin dosage: unknown. During the same period patient was treated with CIFLOX, OFLOCET, LASILIX, TRAMADOL, ORBENIN CAP, TRANSIPEG, VOLTAREN. Patient was hospitalized. Patient recovered.

Rifadin Side Effects Report #4626734-1
Rifadin side effect was reported by a Consumer or non-health professional from on Mar 25, 2005. Female patient, child 12 years of age, was treated with Rifadin. After drug was administered, patient experienced the following side effects: angioneurotic oedema, cheilitis, eosinophilia, hepatocellular damage, lymphadenopathy, lymphocytic infiltration, neutropenia, purpura. Rifadin dosage: unknown. During the same period patient was treated with AMIKACIN, TAZOCILLINE, TRIFLUCAN, VANCOMYCIN. Patient was hospitalized. Patient recovered.

Rifadin Side Effects Report #4635990-5
Rifadin side effect was reported by a Consumer or non-health professional from on Mar 25, 2005. Female patient, child 12 years of age, was treated with Rifadin. After drug was administered, patient experienced the following side effects: angioneurotic oedema, cheilitis, eosinophilia, hepatocellular damage, lymphadenopathy, lymphocytic infiltration, neutropenia, purpura. Rifadin dosage: unknown. During the same period patient was treated with AMIKACIN, TAZOCILLINE, TRIFLUCAN, VANCOMYCIN. Patient was hospitalized. Patient recovered.

Rifadin Side Effects Report #4811120-1
Rifadin side effect was reported by a Consumer or non-health professional from on Mar 25, 2005. Female patient, child 12 years of age, was treated with Rifadin. After drug was administered, patient experienced the following side effects: angioneurotic oedema, cheilitis, eosinophilia, hepatocellular damage, lymphadenopathy, lymphocytic infiltration, neutropenia, purpura. Rifadin dosage: unknown. During the same period patient was treated with AMIKLIN, TAZOCILLINE, TRIFLUCAN, VANCOCIN. Patient was hospitalized. Patient recovered.


Rifadin Side Effects Report #4996427-X
Rifadin side effect was reported by a Consumer or non-health professional from on Mar 25, 2005. Female patient, child 12 years of age, was treated with Rifadin. After drug was administered, patient experienced the following side effects: angioneurotic oedema, cheilitis, dermatitis, eosinophilia, hepatocellular damage, leukopenia, lymphadenopathy, lymphocytic infiltration. Rifadin dosage: unknown. During the same period patient was treated with AMIKLIN, TAZOCILLINE, TRIFLUCAN, VANCOCINE. Patient was hospitalized. Patient recovered.

Rifadin Side Effects Report #5034055-0
Rifadin side effect was reported by a Consumer or non-health professional from on Mar 25, 2005. Female patient, child 12 years of age, was treated with Rifadin. After drug was administered, patient experienced the following side effects: angioneurotic oedema, cheilitis, eosinophilia, hepatocellular damage, lymphadenopathy, lymphocytic infiltration, neutropenia, purpura. Rifadin dosage: unknown. During the same period patient was treated with AMIKLIN, TAZOCILLINE, TRIFLUCAN, VANCOCINE. Patient was hospitalized. Patient recovered.